Augmedics, an augmented reality company, reached a new funding milestone months after closing its series B financing.
The company raised $36 million in an oversubscribed series C financing with the help of Israel-U.S. investors, according to a March 30 news release. The series C financing comes eight months after Augmedics closed a $21 million series B financing. The total funding is now $63 million.
Augmedics creates augmented reality surgical imaging guidance. Its Xvision system has been used by spine surgeons across the U.S.